1
NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
Condition(s):Menkes Disease; Occipital Horn SyndromeLast Updated:January 10, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Menkes Disease; Occipital Horn SyndromeLast Updated:January 10, 2023Recruiting
Condition(s):Autonomic Failure; Pure Autonomic Failure; Multiple System Atrophy; Parkinson Disease; Orthostatic HypotensionLast Updated:March 26, 2024Recruiting
Condition(s):HypotensionLast Updated:March 1, 2024Recruiting
Condition(s):Autonomic Dysfunction; Orthostatic IntoleranceLast Updated:March 1, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.